In parallel, genomic profiling has revealed recurrent mutations in TP53, HGF, epidermal growth factor receptor, TERT, and CDKN2A, suggesting that OSSN shares common oncogenic pathways with other squamous cell carcinomas. This evidence concerns the gene EGFR and squamous cell carcinoma.